Risk Assessment: How Aggressive is Your Prostate Cancer?
The panel explains how doctors use all available information about a patient’s prostate cancer to determine the chance of the cancer coming back, and how that shapes treatment decisions. Highlights of this video include:
- “Risk assessment” or “risk stratification” refers to risk of recurrence, and why it matters for your treatment plan
- How PSA levels, Gleason grade groups, and imaging are combined to categorize cancer risk
- How newer genomic tests can reveal whether a cancer may be more aggressive than it appears
- Why your personal goals and concerns should be part of every treatment conversation
Speakers:
Jim C. Hu, MD, MPH, Professor of Urology, Weill Cornell Medicine
Phillip Koo, MD, Chief Medical Officer, Prostate Cancer Foundation
Neha Vapiwala, MD, Professor of Radiation Oncology, University of Pennsylvania